Iberdomide is a medication that works by helping to regulate the immune system and fight cancer cells. It belongs to a class of drugs called immunomodulators, which are commonly used in the treatment of multiple myeloma.

Ixazomib is an oral medication that belongs to a group of drugs called proteasome inhibitors. It works by blocking certain proteins in cancer cells, which helps to slow or stop the growth of these cells. It is specifically designed to treat multiple myeloma.

Dexamethasone is a corticosteroid medication that helps reduce inflammation and suppress the immune system. In cancer treatment, it is often used in combination with other medications to enhance their effectiveness and manage certain side effects of treatment.

Multiple myeloma – A type of blood cancer that develops in plasma cells, which are white blood cells that help fight infections. These abnormal plasma cells accumulate in the bone marrow, where they interfere with the production of normal blood cells. The disease typically affects multiple areas of the body, particularly the bones, leading to the formation of tumors within the bone marrow. As the condition progresses, it can cause bone pain, weakness, fatigue, and make bones more susceptible to fractures. Multiple myeloma also often leads to decreased kidney function and a reduction in healthy blood cells.